Gabriele Petry

发表

Efficacy of Emodepside plus Toltrazuril Oral Suspension for Dogs (Procox®, Bayer) against Trichuris vulpis in Naturally Infected Dogs

G. Altreuther, Gabriele Petry, S. Wolken, 2013, Parasitology Research.

Efficacy of Procox® Oral Suspension for Dogs (0.1% Emodepside and 2% Toltrazuril) against Experimental Nematode (Toxocara cati and Ancylostoma tubaeforme) Infections in Cats

K. Krieger, Gabriele Petry, E. Kruedewagen, 2011, Parasitology Research.

Efficacy of Emodepside/Toltrazuril Suspension (Procox® Oral Suspension for Dogs) against Mixed Experimental Isospora felis/Isospora rivolta Infection in Cats

Andreas Kampkoetter, K. Krieger, Gabriele Petry, 2011, Parasitology Research.

Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs

C. Genchi, B. Lawrenz, M. Genchi, 2015, Parasitology Research.

Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing emodepside, praziquantel and tigolaner, in treating cats naturally infested with fleas and/or ticks

R. Farkas, N. Mencke, K. Hellmann, 2022, Current research in parasitology & vector-borne diseases.

Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum

C. Böhm, F. Barthel, R. Schaper, 2017, Parasitology Research.

Treatment of Naturally Notoedres cati-infested Cats with a Combination of Imidacloprid 10 % / Moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer)

K. Hellmann, F. Krämer, Gabriele Petry, 2013, Parasitology Research.

Evaluation of the Efficacy of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the Prevention of Dirofilaria repens Infection in Dogs

C. Genchi, M. Genchi, R. Schaper, 2013, Parasitology Research.

Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats

D. Otranto, M. Pombi, G. Capelli, 2019, Parasites & Vectors.

Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.

G. Crescenzo, D. Otranto, F. Dantas-Torres, 2016, Veterinary parasitology.

Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs

C. Genchi, B. Lawrenz, M. Genchi, 2015, Parasitology Research.

Comparison of the palatability of a new flavoured Drontal® plus tablet (Drontal® plus treat 10 kg) and Milbemax® chewable tablets when presented to privately owned dogs.

J. Fourie, Gabriele Petry, S. Wolken, 2014 .

Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis

G. von Samson-Himmelstjerna, C. Strube, M. Schnyder, 2020, Parasites & Vectors.

Prevention of Lactogenic Toxocara cati Infections in Kittens by Application of an Emodepside/Praziquantel Spot-on (Profender®) to the Pregnant Queen

C. Strube, C. Böhm, R. Schaper, 2015, Parasitology Research.

Efficacy of Emodepside plus Toltrazuril Oral Suspension for Dogs (Procox®, Bayer) against Trichuris vulpis in Naturally Infected Dogs

G. Altreuther, Gabriele Petry, S. Wolken, 2013, Parasitology Research.

Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing tigolaner, emodepside and praziquantel, in treating cats with mixed infection with intestinal nematodes, cestodes and/or lungworms

R. Farkas, S. Morelli, A. di Cesare, 2022, Current research in parasitology & vector-borne diseases.

Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi) in Comparison to an Untreated Control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs

A. di Cesare, F. Veronesi, G. Morganti, 2017, Parasitology Research.

Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats

D. Otranto, M. Pombi, G. Capelli, 2019, Parasites & Vectors.

Evaluation of the Efficacy of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the Prevention of Dirofilaria repens Infection in Dogs

C. Genchi, M. Genchi, R. Schaper, 2013, Parasitology Research.